Recombinant Protein Production pH Control and Signal Peptide Optimization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Recombinant protein production in cell culture often results in the formation of low molecular weight (LMW) species, which are impurities that can affect the efficacy and safety of protein drug products and require additional purification steps, making it desirable to reduce their formation during the cell culture process.

Innovation Solution

The methods involve controlling the pH of the cell culture medium to maintain it at about 6.90 or less and using a signal peptide with a GGG codon for glycine residues in the secretory signal peptide to reduce the expression of alternative splice variant isoforms, thereby minimizing LMW species in the recombinant protein composition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional cell culture methods are used to produce recombinant proteins, then protein production is achieved, but low molecular weight species are formed as impurities

Engineering Contradiction:
Improverecombinant protein productionVSAvoidlow molecular weight species formation
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent applies parameter changes by optimizing pH control during cell culture to maintain pH between 6.6-7.2, which reduces the formation of low molecular weight species while maintaining protein production. This parameter optimization directly addresses the contradiction by changing the cultural conditions to favor full-length protein synthesis over truncated forms.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs preliminary action by designing expression constructs with specific features (signal peptide optimization, codon usage) before cell culture to prevent the formation of low molecular weight species. The nucleic acid sequences are engineered in advance to minimize alternative splicing and proteolytic cleavage, thereby preventing impurity formation before it occurs during production.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If additional purification steps are added to remove LMW species, then product quality is improved, but manufacturing complexity increases

Engineering Contradiction:
Improveproduct qualityVSAvoidpurification process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies the extraction principle by removing the need for additional purification steps through upstream process optimization. By controlling cell culture parameters and expression construct design to minimize LMW species formation, the harmful impurities are prevented at the source, eliminating the need for separate removal steps and simplifying the overall manufacturing process.

Inventive Principle:
Principle #2Taking out (Extraction)

3Object-generated harmful factors

If pH is controlled at about 6.90 or less during cell culture, then LMW species are reduced, but process control complexity increases

Engineering Contradiction:
ImproveLMW species amountVSAvoidpH control requirement
Core Design Contradiction:
Object-generated harmful factorsVSEase of operation

Solution Approach 1:

The patent applies parameter changes by establishing a specific pH range (6.6-7.2) that balances LMW species reduction with ease of operation. This optimized parameter range achieves impurity reduction while remaining within the operational capabilities of standard bioreactor systems, making the process both effective and manageable.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20240209115A1Methods for reducing low molecular weight species of recombinantly-produced proteins
Publication Date: 2024.06.27 AMGEN RESEARCH (MUNICH) GMBH
  • US20240209115A1 patent drawing
  • US20240209115A1 patent drawing
  • US20240209115A1 patent drawing

AI summary

The present invention relates to methods for reducing low molecular weight species of recombinantly-produced proteins. In particular, methods of reducing the formation of low molecular weight species produced by a host cell during the cell culture process through pH control of the production cell culture are disclosed. Also disclosed are methods for reducing or eliminating the generation of alternative splice variants by a host cell during production of a recombinant protein.